Recombinant Proteins

p53
LBP
CEA
HLA
TCL
TTC
NPM
MAF
Bax
BID

EDA2R Human

Ectodysplasin A2 Receptor Human Recombinant

EDA2R Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 161 amino acids (1-138 a.a) and having a molecular mass of 17.7kDa.
EDA2R is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT907
Source
Escherichia Coli.
Appearance
Sterile Filtered clear solution.

EDA2R Human, Sf9

Ectodysplasin A2 Receptor Human Recombinant, Sf9

EDA2R Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 380 amino acids (1-138a.a.) and having a molecular mass of 42.5kDa (Molecular size on SDS-PAGE will appear at approximately 40-57kDa). EDA2R is expressed with a 242 amino acid hIgG-His tag at C-Terminus and purified by proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT976
Source

Sf9, Baculovirus cells.

Appearance
Sterile Filtered clear solution.

EDAR Human

Ectodysplasin A Receptor Human Recombinant

EDAR Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 445 amino acids (27-448 a.a) and having a molecular mass of 48.2kDa. 
EDAR is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT1071
Source
Escherichia Coli.
Appearance
Sterile Filtered clear solution.

EDAR Human, Sf9

Ectodysplasin A Receptor Human Recombinant, Sf9

EDAR produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 413 amino acids (27-187a.a.) and having a molecular mass of 45.6kDa. (Molecular size on SDS-PAGE will appear at approximately 40-57kDa).
EDAR is expressed with a 249 amino acid hIgG-His-tag at C-Terminus and purified by proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT1134
Source

Sf9, Baculovirus cells.

Appearance

Sterile filtered colorless solution.

Definition and Classification

Ectodysplasin A (EDA) is a protein encoded by the EDA gene, belonging to the tumor necrosis factor (TNF) family. It plays a crucial role in the development of ectodermal tissues such as skin, hair, teeth, and certain glands . EDA exists in two main splice variants: EDA-A1 and EDA-A2, which bind to different receptors .

Biological Properties

Key Biological Properties: EDA is a transmembrane protein that functions as a homotrimer. It is involved in the formation of various ectodermal derivatives during prenatal development .

Expression Patterns: EDA is primarily expressed in ectodermal tissues, including skin, hair follicles, and glands .

Tissue Distribution: EDA is distributed in tissues derived from the ectoderm, such as the epidermis, hair follicles, teeth, and sweat glands .

Biological Functions

Primary Biological Functions: EDA is essential for the morphogenesis of skin appendages, including hair, teeth, and glands . It also plays a role in the development of feathers in birds and scales in fish .

Role in Immune Responses and Pathogen Recognition: EDA signaling has been implicated in the regulation of immune responses, particularly in the context of inflammation and pathogen recognition .

Modes of Action

Mechanisms with Other Molecules and Cells: EDA exerts its effects by binding to its receptors, EDAR and EDA2R. EDA-A1 binds to EDAR, while EDA-A2 binds to EDA2R .

Binding Partners and Downstream Signaling Cascades: Upon binding to its receptors, EDA activates the NF-κB signaling pathway through the recruitment of the EDAR-associated death domain (EDARADD) adapter protein . This signaling cascade leads to the transcription of target genes involved in the development of ectodermal tissues .

Regulatory Mechanisms

Regulatory Mechanisms Controlling Expression and Activity: The expression and activity of EDA are regulated at multiple levels, including transcriptional regulation and post-translational modifications .

Transcriptional Regulation: The EDA gene is regulated by various transcription factors that control its expression during development .

Post-Translational Modifications: EDA undergoes proteolytic processing to generate its active form, which can then bind to its receptors and initiate signaling .

Applications

Biomedical Research: EDA and its signaling pathway are studied extensively in the context of developmental biology and genetic disorders .

Diagnostic Tools: Mutations in the EDA gene are associated with ectodermal dysplasias, which can be diagnosed through genetic testing .

Therapeutic Strategies: Recombinant EDA protein has been explored as a potential therapeutic strategy for treating ectodermal dysplasias .

Role in the Life Cycle

Development: EDA is critical for the proper development of ectodermal tissues during embryogenesis .

Aging and Disease: Dysregulation of EDA signaling has been linked to various diseases, including ectodermal dysplasias, cancer, and metabolic disorders .

© Copyright 2024 Thebiotek. All Rights Reserved.